Next-generation DNA sequencing, regulation, and the limits of paternalism: The next challenge

JAMA

Volumn 306, Issue 21, 2011, Pages 2376-2377

  Evans, James P ^a   Berg, Jonathan S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA SEQUENCE; GENE TECHNOLOGY; GENETIC SCREENING; GENOME ANALYSIS; HETEROZYGOTE; HUMAN; MENTAL STRESS; MICROARRAY ANALYSIS; NOTE; PATERNALISM; PATIENT IDENTIFICATION; PATIENT INFORMATION; PRIORITY JOURNAL; PUBLIC HEALTH; SEQUENCE ANALYSIS; SOCIOECONOMICS;

EID: 83055182072     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1788     Document Type: Note

References (10)

1. Gahl WA, Markello TC, Toro C, et al. The NIH undiagnosed diseases program: insights into rare diseases [published online September 26, 2011]. Genet Med. doi: 10.1097/GIM.0b013e318232a005.
2. de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer. 2005; 4(3):233-237.
3. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP working group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11 (1):35-41.
4. Stevenson DA, Carey JC. Contribution of malformations and genetic disorders to mortality in a children's hospital. Am J Med Genet A. 2004;126A(4):393- 397.
5. Counsyl Genomics Web site. https://www.counsyl.com. Accessed November 2, 2011.
6. Evans JP, Green RC. Direct to consumer genetic testing: avoiding a culture war. Genet Med. 2009;11(8):568-569.
7. Vorhous D. DTC genetic testing and the FDA: is there an end in sight to the regulatory uncertainty? Genomics law report Web site. http://www .genomicslawreport.com/index.php/2011/06/16/dtc-genetic-testing-and-the -fda-is-there-an-end-in-sight-to-the-regulatory-uncertainty. Accessed November 2, 2011.
8. Kutz G; Forensic Audits and Special Investigations, Government Accountability Office. Direct to consumer genetic tests: misleading test results are further complicated by deceptive marketing and other questionable practices; July 22, 2010. http://www.gao.gov/new.items/d10847t.pdf. Accessed November 2, 2011.
9. 23andme Web site. https://www.23andme.com/exome. Accessed November 2, 2011.
10. Creighton S, Almqvist EW, MacGregor D, et al. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet. 2003;63(6):462-475. (Pubitemid 36944091)